Simultaneous determination of risperidone and 9-hydroxyrisperidone enantiomers in human blood plasma by liquid chromatography with electrochemical detection

Journal of Pharmaceutical and Biomedical Analysis

Volumn 50, Issue 5, 2009, Pages 905-910

  Locatelli, Igor ^a   Mrhar, Aleš ^a   Grabnar, Iztok ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

9 Hydroxyrisperidone enantiomers; Chiral separation; Coulometric electrochemical detection; Liquid chromatography; Risperidone

Indexed keywords

CARBAMAZEPINE; DIAZEPAM; ENALAPRILAT; FENOTEROL; LORAZEPAM; NITRAZEPAM; NORFLOXACIN; PALIPERIDONE; RISPERIDONE; SERTRALINE;

ACCURACY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG HYDROXYLATION; DRUG ISOLATION; DRUG RETENTION; ELECTROCHEMICAL DETECTION; ENANTIOMER; ENANTIOSELECTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAXIMUM PLASMA CONCENTRATION; PRIORITY JOURNAL; PROCESS DEVELOPMENT; SCHIZOPHRENIA; SOLID PHASE EXTRACTION; STEREOCHEMISTRY; VALIDATION PROCESS;

ANTIPSYCHOTIC AGENTS; BUFFERS; CALIBRATION; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; ELECTROCHEMISTRY; HUMANS; ISOXAZOLES; METHANOL; PHOSPHATES; PYRIMIDINES; REPRODUCIBILITY OF RESULTS; RISPERIDONE; STEREOISOMERISM; TIME FACTORS;

EID: 70349163638     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.06.013     Document Type: Article

References (31)

1. Chouinard G., and Arnott W. Can. J. Psychiatry 38 Suppl. 3 (1993) S89-S95
2. Hirschfeld R.M., Keck Jr. P.E., Kramer M., Karcher K., Canuso C., Eerdekens M., and Grossman F. Am. J. Psychiatry 161 (2004) 1057-1065
3. Heykants J., Huang M.L., Mannens G., Meuldermans W., Snoeck E., Van Beijsterveldt L., Van Peer A., and Woestenborghs R. J. Clin. Psychiatry 55 Suppl. (1994) 13-17
4. Mannens G., Huang M.L., Meuldermans W., Hendrickx J., Woestenborghs R., and Heykants J. Drug Metab. Dispos. 21 (1993) 1134-1141
5. Fang J., Bourin M., and Baker G.B. Naunyn Schmiedebergs Arch. Pharmacol. 359 (1999) 147-151
6. Yasui-Furukori N., Hidestrand M., Spina E., Facciola G., Scordo M.G., and Tybring G. Drug Metab. Dispos. 29 (2001) 1263-1268
7. Yasui-Furukori N., Mihara K., Kondo T., Kubota T., Iga T., Takarada Y., De Vries R., Kaneko S., and Tateishi T. J. Clin. Pharmacol. 43 (2003) 122-127
8. Odou P., Levron J., Luyckx M., Brunet C., and Robert H. Clin. Drug Invest. 19 (2000) 283-292
9. Spina E., Avenoso A., Facciola G., Salemi M., Scordo M.G., Ancione M., Madia A.G., and Perucca E. Psychopharmacology (Berl.) 153 (2001) 238-243
10. Vermeir M., Naessens I., Remmerie B., Mannens G., Hendrickx J., Sterkens P., Talluri K., Boom S., Eerdekens M., van Osselaer N., and Cleton A. Drug Metab. Dispos. (2008)
11. Yang L.P., and Plosker G.L. CNS Drugs 21 (2007) 417-425
12. Avenoso A., Facciola G., Salemi M., and Spina E. J. Chromatogr. B: Biomed. Sci. Appl. 746 (2000) 173-181
13. LLerena A., Berecz R., Dorado P., de la Garza C.S., Norberto M.J., Caceres M., and Gutierrez J.R. J. Chromatogr. B 783 (2003) 213-219
14. Nagasaki T., Ohkubo T., Sugawara K., Yasui N., Furukori H., and Kaneko S. J. Pharm. Biomed. Anal. 19 (1999) 595-601
15. Olesen O.V., and Linnet K. J. Chromatogr. B: Biomed. Sci. Appl. 698 (1997) 209-216
16. Titier K., Deridet E., Cardone E., Abouelfath A., and Moore N. J. Chromatogr. B 772 (2002) 373-378
17. Woestenborghs R., Lorreyne W., Van Rompaey F., and Heykants J. J. Chromatogr. 583 (1992) 223-230
18. Aravagiri M., Marder S.R., Van Putten T., and Midha K.K. J. Pharm. Sci. 82 (1993) 447-449
19. Aravagiri M., Marder S.R., Wirshing D., and Wirshing W.C. Pharmacopsychiatry 31 (1998) 102-109
20. Balant-Gorgia A.E., Gex-Fabry M., Genet C., and Balant L.P. Ther. Drug Monit. 21 (1999) 105-115
21. Le Moing J.P., Edouard S., and Levron J.C. J. Chromatogr. 614 (1993) 333-339
22. Price M.C., and Hoffman D.W. Ther. Drug Monit. 19 (1997) 333-337
23. Aravagiri M., and Marder S.R. J. Mass Spectrom. 35 (2000) 718-724
24. Bhatt J., Subbaiah G., and Singh S. Rapid Commun. Mass Spectrom. 20 (2006) 2109-2114
25. Flarakos J., Luo W., Aman M., Svinarov D., Gerber N., and Vouros P. J. Chromatogr. A 1026 (2004) 175-183
26. Remmerie B.M., Sips L.L., de Vries R., de Jong J., Schothuis A.M., Hooijschuur E.W., and van de Merbel N.C. J. Chromatogr. B 783 (2003) 461-472
27. Danel C., Barthelemy C., Azarzar D., Robert H., Bonte J.P., Odou P., and Vaccher C. J. Chromatogr. A 1163 (2007) 228-236
28. Cabovska B., Cox S.L., and Vinks A.A. J. Chromatogr. B 852 (2007) 497-504
29. De Meulder M., Remmerie B.M., de Vries R., Sips L.L., Boom S., Hooijschuur E.W., van de Merbel N.C., and Timmerman P.M. J. Chromatogr. B 870 (2008) 8-16
30. Guidance for Industry, Bioanalytical Method Validation, US Department of Health and Human Services, FDA, CDER, Rockville, MD, 2001, available at: http://www.fda.gov/cder/guidance/4252fnl.pdf.
31. Hermansson J., and Grahn A. J. Chromatogr. A 694 (1995) 57-69